Recent Finacing
Recent Raise
Pneumagen is a clinical‑stage biotech from the University of St Andrews developing Neumifil, an intranasal engineered multivalent carbohydrate‑binding module (mCBM) via its GlycoTarge™ platform to block respiratory virus entry.
Focus Areas
Recent Investors
Total Raised
Funding rounds
Investors
